🇩🇪 Xmab5574 in Germany

Xmab5574 (tafasitamab) regulatory status in Germany.

Marketing authorisation

BfArM

  • Local brand name: Minjuvi
  • Status: approved

Xmab5574 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Germany

Frequently asked questions

Is Xmab5574 approved in Germany?

Yes. BfArM has authorised it.

Who is the marketing authorisation holder for Xmab5574 in Germany?

Morphosys Us Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.